搜索筛选:
搜索耗时2.9211秒,为你在为你在102,285,761篇论文里面共找到 16 篇相符的论文内容
类      型:
[会议论文] 作者:Fa-Jun NAN,Jian-Feng LIU, 来源:中国神经科学学会第九届全国学术会议暨第五届会员代表大会 年份:2011
Many GPCR agonists can activate receptor-tyrosine-kinases (RTKs) through transactivation, the mechanisms of which are poorly defined.Here, we have investigated IGF-1 receptor (IGF-1R) transactivation...
[期刊论文] 作者:Lin-lin GAN,Lin-hai CHEN,Fa-jun NAN, 来源:中国药理学报(英文版) 年份:2017
α-Ketoglutarate (α-KG),a pivotal metabolite in energy metabolism,has been implicated in nonalcoholic fatty liver disease (NAFLD) and several cancers.It is rec...
[期刊论文] 作者:Chen-Xi Yu,Bing-Yan Wei,Xue-Qing Kong,Cai-Guang Yang,Fa-Jun Nan, 来源:中国化学(英文版) 年份:2021
Methicillin-resistant Staphylococcus aureus (MRSA) has become a major threat on public health because of the increase of clinically isolated strains that exhibi...
[期刊论文] 作者:Yu-ting LU,Yu-feng Xiao,Yu-feng Li,Jia Li,Fa-jun Nan,Jing-ya Li, 来源:中国药理学报(英文版) 年份:2019
Palmitate (PA) exposure induces stress conditions featuring ROS accumulation and upregulation of p62 expression,resulting in autophagic flux blockage and cell a...
[期刊论文] 作者:Hai-ning HU,Ping-zheng ZHOU,Fei CHEN,Min LI,Fa-jun NAN,Zhao-bing GAO, 来源:中国药理学报(英文版) 年份:2013
[期刊论文] 作者:Jin-feng YUE,Guan-hua QIAO,Ni LIU,Xue-qin CHEN,Fa-jun NAN,Zhao-bing GAO, 来源:中国药理学报(英文版) 年份:2016
[期刊论文] 作者:Xiao-yin WANG,Shu-yong ZHANG,Jing LI,Hua-nan LIU,Xin XIE,Fa-jun NAN, 来源:中国药理学报(英文版) 年份:2014
[期刊论文] 作者:Jin-tao Wang,Yue-ming Zheng,Yue-ting Chen,Min Gu,Zhao-bing Gao,Fa-jun Nan, 来源:中国药理学报(英文版) 年份:2020
Nav1.7 channels are mainly distributed in the peripheral nervous system.Blockade of Nav1.7 channels with small-molecule inhibitors in humans might provide pain...
[会议论文] 作者:Pingzheng Zhou,Haibo Yu,Min Gu,Fa-jun Nan,Zhaobing Gao,Min Li, 来源:上海市细胞生物学学会第十届CST细胞生物学青年论坛 年份:2014
Pharmacological augmentation of neuronal KCNQ muscarinic (M) currents by drugs such as retigabine (RTG) represents a first-in-class therapeutic to treat certain...
[会议论文] 作者:Jin-feng Yue,Guanhua Qiao,Ni Liu,Xueqin Chen,Fa-jun NAN,Zhao-bing GAO, 来源:第十四次全国暨国际生物物理大会 年份:2015
[期刊论文] 作者:Yi Liu,Ke-xin Zhu,Lei Cao,Zhi-fu Xie,Min Gu,Wei Lü,Jing-ya Li,Fa-jun Nan, 来源:中国药理学报(英文版) 年份:2020
Berberine (BBR) exhibits diverse bioactivities,including anticancer activity;but its poor druggability limits its applications.In this study,we designed and syn...
[期刊论文] 作者:Ling-ling CHEN,Jia LI,Jing-ya LI,Qun-li LUO,Wei-feng MAO,Qiang SHEN,Fa-jun NAN,Qi-zhuang YE, 来源:中国药理学报(英文版) 年份:2004
AIM: To screen antifungal drug candidates using in vitro and in vivo assays based on type I methionine aminopeptidase from Saccharomyces cerevisiae (ScMetAP1)....
[期刊论文] 作者:Bo-han Li,Mei Zhang,Ya-nan Duan,Lin Shuai,Hao-wen Jiang,Jia Li,Fa-jun Nan,Jing-ya Li, 来源:中国药理学报:英文版 年份:2021
Beige adipocytes have been considered as a potential strategy in anti-obesity therapy because of its thermogenic capacity.AMP-activated protein kinase(AMPK)plays important roles in regulating adipose tissue function.C29 is a novel pyrazolon......
[期刊论文] 作者:Yan-Hui Zhu,Meng Zhang,Qun-Yi Li,Qing Liu,Jie Zhang,Yun-Yun Yuan,Fa-Jun Nan,Ming-Wei Wang,, 来源:Chinese Chemical Letters 年份:2014
The structure–activity relationship(SAR) study of a 1 2 3 4 4a 9a-hexahydro-1H-xanthene series of selective,human glucocorticoid receptor a(hGRa) antagonists i...
[期刊论文] 作者:XIE,Run-tao ZHANG,Da-kai CHEN,Min GU,Shi-chao CUI,Yang-ming ZHANG,Xin-wen ZHANG,Yan-yan YU,Jia LI,Fa-jun NAN, 来源:中国药理学报(英文版) 年份:2018
Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome characterized by hepatic steatosis.NAFLD is closely linked to obesity,insulin resistance and dy...
[期刊论文] 作者:Xin-wen Zhang,Chen-dong Zhou,Jian-peng Yin,Yan-yan Yu,Shi-chao Cui,Hao-wen Jiang,Teng-teng Li,Jia Li,Fa-jun Nan, 来源:中国药理学报(英文版) 年份:2021
Dyslipidemia is a chronic metabolic disease characterized by elevated levels of lipids in plasma.Recently,various studies demonstrate that the increased activit...
相关搜索: